TR199902530T2 - Dayanikli hale getirilmis tibolon terkipleri. - Google Patents

Dayanikli hale getirilmis tibolon terkipleri.

Info

Publication number
TR199902530T2
TR199902530T2 TR1999/02530T TR9902530T TR199902530T2 TR 199902530 T2 TR199902530 T2 TR 199902530T2 TR 1999/02530 T TR1999/02530 T TR 1999/02530T TR 9902530 T TR9902530 T TR 9902530T TR 199902530 T2 TR199902530 T2 TR 199902530T2
Authority
TR
Turkey
Prior art keywords
tibolone
preparations
starch
weight
stabilized
Prior art date
Application number
TR1999/02530T
Other languages
English (en)
Inventor
Haan De Pieter
Cornelis Petrus Rovers Adrianus
Antonia Maria Lambregts-De Hurk Theodora
Antonius Maria Zwinkels Jocominus
Morita Ryoichi
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of TR199902530T2 publication Critical patent/TR199902530T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bulus, tibolonun etkin bir miktarini (genel olarak, agirlikta %0.1' den 10'a kadar) ve nisasta-ihtiva eden eczacilik ile ilgili olarak kabul edilebilir bir tasiyici (ayni zamanda, temel tanelenme olarak da ifade edilmektedir) ihtiva eden, bir tablet ya da bir kapsül gibi, eczaciliga ait, bir dozaj birimine mahsus olup, ki içinde, tasiyici, nisastanin, agirlikta %10' dan 100'e kadarini ihtiva etmektedir. Böylelikle kuru muhafazaya ve aktif terkip maddesinin daha düsük dozlarina izin veren, daha dayanikli bir tibolon formülasyonu elde edilmektedir.
TR1999/02530T 1997-04-22 1998-04-20 Dayanikli hale getirilmis tibolon terkipleri. TR199902530T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201180 1997-04-22
PCT/EP1998/002361 WO1998047517A1 (en) 1997-04-22 1998-04-20 Stabilized tibolone compositions

Publications (1)

Publication Number Publication Date
TR199902530T2 true TR199902530T2 (tr) 2000-05-22

Family

ID=8228228

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02530T TR199902530T2 (tr) 1997-04-22 1998-04-20 Dayanikli hale getirilmis tibolon terkipleri.

Country Status (25)

Country Link
US (6) US6399594B2 (tr)
EP (1) EP0975348B1 (tr)
JP (1) JPH10316573A (tr)
KR (1) KR100580855B1 (tr)
CN (2) CN1146424C (tr)
AR (1) AR012480A1 (tr)
AT (1) ATE281836T1 (tr)
AU (1) AU742037B2 (tr)
BR (1) BR9809268A (tr)
CA (1) CA2288070A1 (tr)
DE (1) DE69827484T2 (tr)
DK (1) DK0975348T3 (tr)
ES (1) ES2232949T3 (tr)
HU (1) HUP0001780A3 (tr)
ID (1) ID22763A (tr)
IL (1) IL123984A (tr)
NO (1) NO995127L (tr)
NZ (1) NZ338028A (tr)
PL (1) PL190227B1 (tr)
PT (1) PT975348E (tr)
RU (1) RU2207133C2 (tr)
TR (1) TR199902530T2 (tr)
TW (1) TW570798B (tr)
WO (1) WO1998047517A1 (tr)
ZA (1) ZA983169B (tr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK284569B6 (sk) * 1998-10-16 2005-06-02 Akzo Nobel N.V. Vysoko čistá zlúčenina (7alfa, 17alfa)-17-hydroxy-7-metyl-19-nor- 17-pregn-5(10)-én-20-ín-3-ón, spôsob jej prípravy a farmaceutická dávková jednotka s jej obsahom
WO2000051570A1 (fr) * 1999-02-26 2000-09-08 Shionogi & Co., Ltd. Capsules molles a croquer presentant des proprietes d'administration ameliorees et leur procede de production
US20040229854A1 (en) * 2000-11-28 2004-11-18 Pieter Haan De Immediate release dosage form for HRT
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
CA2461708C (en) * 2001-09-28 2012-08-07 Nutraceutix, Inc. Delivery system for biological component
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
TW200418525A (en) * 2002-11-20 2004-10-01 Akzo Nobel Nv Coated pharmaceutical tablets containing Tibolone
CN1324041C (zh) * 2003-04-01 2007-07-04 上海迪赛诺医药科技开发有限公司 替勃龙晶型i的制备方法
JP5207432B2 (ja) * 2003-04-29 2013-06-12 エム・エス・ディー・オス・ベー・フェー アンチ溶媒凝固プロセス
AU2004203420B8 (en) * 2003-05-23 2008-02-21 N.V. Organon Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
WO2005105278A2 (en) * 2004-05-05 2005-11-10 Akzo Nobel N.V. Antisolvent emulsion solidification process
WO2005117899A1 (en) * 2004-06-02 2005-12-15 Cipla Limited Pharmaceutical composition comprising tibolone and process for procuding the same
WO2005120517A1 (en) * 2004-06-07 2005-12-22 Strides Arcolab Limited Stable liquid suspension formulation comprising synthetic steroids and process for producing the same
CZ300465B6 (cs) * 2007-07-25 2009-05-27 Zentiva, A. S. Zpusob výroby komprimované farmaceutické formulace s obsahem tibolonu
CN102085193B (zh) * 2009-12-08 2013-11-06 北京以岭生物工程技术有限公司 一种替勃龙口腔崩解片及其制备方法
CN104345098B (zh) * 2013-08-05 2016-04-13 华润紫竹药业有限公司 一种测定替勃龙片剂中抗氧剂含量的方法
WO2017191266A1 (en) 2016-05-04 2017-11-09 Mithra Pharmaceuticals S.A. Use of sugar-alcohols in tibolone compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
CH676470A5 (tr) * 1988-02-03 1991-01-31 Nestle Sa
IE63051B1 (en) 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
ZA941464B (en) 1993-03-05 1994-09-27 Akzo Nv Use of pregnane derivative
ES2185666T3 (es) 1993-09-03 2003-05-01 Smithkline Beecham Corp Formulacion estabilizada para comprimidos.
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation

Also Published As

Publication number Publication date
HK1023508A1 (en) 2000-09-15
US20040142028A1 (en) 2004-07-22
AU8014698A (en) 1998-11-13
HUP0001780A2 (hu) 2000-12-28
DK0975348T3 (da) 2005-03-07
AU742037B2 (en) 2001-12-13
ID22763A (id) 1999-12-09
DE69827484T2 (de) 2005-03-17
CN1494908A (zh) 2004-05-12
KR100580855B1 (ko) 2006-05-17
US20040142031A1 (en) 2004-07-22
TW570798B (en) 2004-01-11
RU2207133C2 (ru) 2003-06-27
US20010005513A1 (en) 2001-06-28
CA2288070A1 (en) 1998-10-29
NO995127D0 (no) 1999-10-21
PT975348E (pt) 2005-01-31
WO1998047517A1 (en) 1998-10-29
ES2232949T3 (es) 2005-06-01
CN1146424C (zh) 2004-04-21
NZ338028A (en) 2001-10-26
HUP0001780A3 (en) 2001-02-28
AR012480A1 (es) 2000-10-18
BR9809268A (pt) 2000-06-27
US6514958B1 (en) 2003-02-04
CN1253503A (zh) 2000-05-17
ATE281836T1 (de) 2004-11-15
US6399594B2 (en) 2002-06-04
EP0975348B1 (en) 2004-11-10
ZA983169B (en) 1998-10-20
US20040142030A1 (en) 2004-07-22
PL190227B1 (pl) 2005-11-30
DE69827484D1 (de) 2004-12-16
IL123984A (en) 2004-09-27
JPH10316573A (ja) 1998-12-02
US20030119801A1 (en) 2003-06-26
PL336658A1 (en) 2000-07-03
KR20010020163A (ko) 2001-03-15
EP0975348A1 (en) 2000-02-02
NO995127L (no) 1999-10-21

Similar Documents

Publication Publication Date Title
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
KR950007841A (ko) 트라마돌 염을 함유하는 서방성 약물 제제
CA2354057A1 (en) Sustained release tablet containing hydrocolloid and cellulose ether
FR2561524B1 (fr) Comprimes de principes actifs pharmaceutiques a delitement rapide, stables au stockage
ATE100708T1 (de) Unbeschichtete pharmazeutische reaktionstablette.
US20020183392A1 (en) Inhibiting oxidative degradation of pharmaceutical formulations
ATE223712T1 (de) Pharmazeutische zusammensetzung von l-dopa ethyl ester
NZ507566A (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
DK0750618T3 (da) Oxazolidinonderivater og farmaceutiske præparater indeholdende dem
FR11C0017I2 (fr) Utilisation de spinosad ou d'une formulation comprennant spinosad
MY104010A (en) Pharmaceutical compositions.
WO2004047809A1 (en) Stable pharmaceutical compositions without a stabilizer
BR9809268A (pt) Unidade de dosagem farmacêutica, processo para fabricação da mesma, e, uso de um produto de amido como um veìculo para unidades de dosagem farmacêutica compreendendo tibolona
NO894616D0 (no) Fremgangsmaate for fremstilling av anti-aterosklerotisk aktive diarylforbindelser.
ES2149990T3 (es) Composiciones farmaceuticas solidas que contienen ingrediente activo de acido (s)-2-(4-isobutilfenil)propionico y celulosa microcristalina y silice coloidal como excipientes.
US4888343A (en) Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
AR002743A1 (es) Esmalte de unas, y la utilizacion de dicho esmalte para la preparacion de un medicamento para el tratamiento de onicomicosis.
ES2065313T3 (es) Tableta con biodisponibilidad mejorada que contiene acido diclorometilendifosfonico como sustancia activa.
ES2176792T3 (es) Tabletas que contienen una resina de intercambio ionico.
HUP9901303A2 (hu) Gyógyszerkészítmény autoimmun betegségek kezelésére
BG94934A (bg) Твърди лекарствени форми за орално приложение,съдържащи ифосфамид като активно вещество
EE9600202A (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm
TR200200198T2 (tr) Düşük dozlu tabletler ve hazırlama yöntemi
RU94040865A (ru) Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью
AU7547100A (en) Alkylpiperidi nylbenzo [d] isoxazole derivatives having psychotropic activity, pharmaceutical compositions containing the same, and a process for the preparation of the active ingredient